RDY Financial Statements From 2010 to 2025

RDY Stock  USD 13.96  0.02  0.14%   
Dr Reddys financial statements provide useful quarterly and yearly information to potential Dr Reddys Laboratories investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Dr Reddys financial statements helps investors assess Dr Reddys' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Dr Reddys' valuation are summarized below:
Gross Profit
177.8 B
Profit Margin
0.1779
Market Capitalization
11.8 B
Enterprise Value Revenue
3.2603
Revenue
299.9 B
We have found one hundred twenty available fundamental measures for Dr Reddys, which can be analyzed and compared to other ratios and to its peers in the sector. All investors should make sure to verify all of Dr Reddys latest market performance against the performance between 2010 and 2025 to make sure the company can sustain itself in the future. Market Cap is likely to rise to about 196.7 B in 2025. Enterprise Value is likely to rise to about 208.9 B in 2025

Dr Reddys Total Revenue

337.09 Billion

Check Dr Reddys financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dr Reddys' main balance sheet or income statement drivers, such as Interest Expense of 2.1 B, Total Revenue of 337.1 B or Gross Profit of 197.6 B, as well as many indicators such as Price To Sales Ratio of 0.7, Dividend Yield of 0.0271 or PTB Ratio of 0.86. RDY financial statements analysis is a perfect complement when working with Dr Reddys Valuation or Volatility modules.
  
Check out the analysis of Dr Reddys Correlation against competitors.

Dr Reddys Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets467.9 B445.6 B325.3 B
Very volatile
Other Current Liabilities70.2 B66.8 B45.5 B
Pretty Stable
Total Current Liabilities69.8 B110.4 B99.4 B
Pretty Stable
Total Stockholder Equity338.8 B322.6 B200.3 B
Pretty Stable
Retained Earnings320.3 B305 B141.2 B
Slightly volatile
Accounts Payable14.3 B24.8 B20.2 B
Pretty Stable
Cash13.6 B8.2 B17 B
Slightly volatile
Other Assets8.6 B8.2 B5.9 B
Slightly volatile
Short Term Investments89.8 B85.5 B44.6 B
Pretty Stable
Inventory76.7 B73.1 B49.7 B
Very volatile
Total Liabilities89.6 B123 B122.5 B
Pretty Stable
Intangible Assets24.7 B42.5 B32.8 B
Very volatile
Common Stock1.1 B959.1 M1.3 B
Pretty Stable
Property Plant Equipment80.1 B76.2 B42.9 B
Slightly volatile
Short and Long Term Debt Total41.6 B23 B53 B
Slightly volatile
Other Liabilities3.1 B2.9 B2.3 B
Slightly volatile
Property Plant And Equipment Net55.3 B88.4 B73.7 B
Pretty Stable
Current Deferred Revenue1.2 B1.3 B1.2 B
Slightly volatile
Non Current Assets Total98.4 B160.4 B128.1 B
Very volatile
Non Currrent Assets Other19.5 B18.5 B7.2 B
Pretty Stable
Cash And Short Term Investments98.4 B93.7 B53.8 B
Pretty Stable
Net Receivables48.4 B92.3 B69 B
Very volatile
Good Will6.5 B4.9 B5.7 B
Pretty Stable
Common Stock Shares OutstandingB958.6 M433.7 M
Slightly volatile
Liabilities And Stockholders Equity223.8 B445.6 B310.8 B
Very volatile
Non Current Liabilities Total20.2 B12.6 B23.2 B
Slightly volatile
Other Current Assets27.4 B26.1 B17.7 B
Very volatile
Total Current Assets299.5 B285.3 B193.6 B
Very volatile
Accumulated Other Comprehensive Income3.4 B3.6 B48 B
Slightly volatile
Short Term Debt27 B16.1 B35.2 B
Slightly volatile
Property Plant And Equipment Gross145.5 B153.1 B363.7 B
Slightly volatile
Net Tangible Assets102.9 B182.7 B104.6 B
Slightly volatile
Long Term Debt Total1.1 B1.2 B5.1 B
Very volatile
Capital Surpluse7.1 B6.4 B6.3 B
Slightly volatile
Cash And Equivalents2.8 B2.6 B1.9 B
Pretty Stable
Net Invested Capital236 B341.6 B207.2 B
Slightly volatile
Net Working Capital90 B174.8 B69.8 B
Slightly volatile
Capital Stock915.2 M959.1 M844.1 M
Slightly volatile

Dr Reddys Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Total Revenue337.1 B321 B177.9 B
Slightly volatile
Gross Profit197.6 B188.1 B104.3 B
Slightly volatile
Operating Income81.8 B77.9 B37.8 B
Slightly volatile
Research Development27.6 B26.3 B16.3 B
Slightly volatile
Cost Of Revenue139.5 B132.9 B73.6 B
Slightly volatile
Income Before Tax86.8 B82.7 B34.6 B
Slightly volatile
Net Income Applicable To Common Shares54.4 B51.8 B20 B
Slightly volatile
Net Income67.2 B64 B26.7 B
Slightly volatile
Depreciation And Amortization17.9 B17.1 B9.2 B
Slightly volatile
Selling General Administrative66 B69.5 B27 B
Slightly volatile
Other Operating Expenses255.3 B243.2 B142 B
Slightly volatile
EBIT88.8 B84.6 B37 B
Slightly volatile
EBITDA106.8 B101.7 B46.2 B
Slightly volatile
Total Operating Expenses115.8 B110.3 B68 B
Slightly volatile
Interest Income2.2 B2.6 B2.2 B
Pretty Stable
Reconciled Depreciation13.9 B17.1 B12.6 B
Slightly volatile
Selling And Marketing Expenses47.6 B53.5 B58.4 B
Slightly volatile

Dr Reddys Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Dividends PaidB7.6 B4.1 B
Slightly volatile
Capital Expenditures33.1 B31.6 B16.6 B
Slightly volatile
Total Cash From Operating Activities54.9 B52.2 B30.5 B
Slightly volatile
Net Income67.2 B64 B27.8 B
Slightly volatile
End Period Cash Flow6.3 B8.2 B6.2 B
Slightly volatile
Stock Based Compensation702 M738.9 M498 M
Slightly volatile
Begin Period Cash Flow7.2 B6.6 B6.1 B
Slightly volatile
Depreciation17.9 B17.1 B10.7 B
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.70.860.6673
Slightly volatile
Dividend Yield0.02710.02870.0345
Pretty Stable
PTB Ratio0.860.850.7952
Pretty Stable
Days Sales Outstanding79.9194.49114
Pretty Stable
Book Value Per Share1.6 K1.5 K1.1 K
Pretty Stable
Operating Cash Flow Per Share258246174
Slightly volatile
Average Payables3.1 B4.6 B4.8 B
Very volatile
Stock Based Compensation To Revenue0.00310.00170.0027
Slightly volatile
Capex To Depreciation1.171.661.426
Very volatile
PB Ratio0.860.850.7952
Pretty Stable
EV To Sales0.690.710.9326
Slightly volatile
ROIC0.07820.150.1084
Pretty Stable
Inventory Turnover2.592.092.0962
Very volatile
Net Income Per Share316301150
Slightly volatile
Days Of Inventory On Hand168181248
Pretty Stable
Payables Turnover4.464.835.8029
Pretty Stable
Sales General And Administrative To Revenue0.150.170.1854
Slightly volatile
Average Inventory8.8 B8.4 B8.8 B
Slightly volatile
Research And Ddevelopement To Revenue0.06760.07370.0893
Very volatile
Capex To Revenue0.0730.08840.0888
Very volatile
Cash Per Share462440349
Very volatile
POCF Ratio5.15.274.6222
Slightly volatile
Interest Coverage37.4135.6325.1482
Slightly volatile
Payout Ratio0.130.140.1875
Pretty Stable
Capex To Operating Cash Flow0.730.690.6094
Very volatile
Days Payables Outstanding76.2578.2765.2524
Pretty Stable
Income Quality0.890.941.2632
Very volatile
ROE0.10.180.1459
Very volatile
EV To Operating Cash Flow7.715.67.204
Slightly volatile
PE Ratio4.084.35.4833
Slightly volatile
Return On Tangible Assets0.110.180.1065
Slightly volatile
Earnings Yield0.140.240.1951
Very volatile
Intangibles To Total Assets0.20.120.1455
Very volatile
Current Ratio2.292.971.8991
Slightly volatile
Tangible Book Value Per Share1.4 K1.3 K915
Pretty Stable
Receivables Turnover4.434.03.2904
Pretty Stable
Graham Number3.4 K3.2 K1.9 K
Slightly volatile
Shareholders Equity Per Share1.6 K1.5 K1.1 K
Pretty Stable
Debt To Equity0.0780.08210.3008
Slightly volatile
Capex Per Share15614894.0581
Slightly volatile
Average Receivables3.2 B3.8 B4.1 B
Slightly volatile
Revenue Per Share1.6 K1.5 KK
Slightly volatile
Interest Debt Per Share187117315
Slightly volatile
Debt To Assets0.05640.05940.1661
Slightly volatile
Enterprise Value Over EBITDA2.242.253.9348
Slightly volatile
Short Term Coverage Ratios4.334.111.8468
Slightly volatile
Price Earnings Ratio4.084.35.4833
Slightly volatile
Operating Cycle248275362
Pretty Stable
Price Book Value Ratio0.860.850.7952
Pretty Stable
Days Of Payables Outstanding76.2578.2765.2524
Pretty Stable
Dividend Payout Ratio0.130.140.1875
Pretty Stable
Price To Operating Cash Flows Ratio5.15.274.6222
Slightly volatile
Pretax Profit Margin0.240.230.173
Slightly volatile
Ebt Per Ebit0.810.961.0199
Pretty Stable
Operating Profit Margin0.110.220.16
Very volatile
Company Equity Multiplier1.931.591.7227
Slightly volatile
Long Term Debt To Capitalization0.01460.01540.0757
Slightly volatile
Total Debt To Capitalization0.07280.07660.2137
Slightly volatile
Return On Capital Employed0.110.210.1616
Very volatile
Debt Equity Ratio0.0780.08210.3008
Slightly volatile
Ebit Per Revenue0.110.220.16
Very volatile
Quick Ratio1.732.211.4031
Slightly volatile
Dividend Paid And Capex Coverage Ratio1.281.21.5976
Pretty Stable
Net Income Per E B T0.990.890.7962
Slightly volatile
Cash Ratio0.08080.08510.2147
Slightly volatile
Cash Conversion Cycle195214304
Pretty Stable
Operating Cash Flow Sales Ratio0.130.150.1599
Pretty Stable
Days Of Inventory Outstanding168181248
Pretty Stable
Days Of Sales Outstanding79.9194.49114
Pretty Stable
Cash Flow Coverage Ratios3.172.611.2662
Slightly volatile
Price To Book Ratio0.860.850.7952
Pretty Stable
Fixed Asset Turnover3.454.183.0627
Slightly volatile
Capital Expenditure Coverage Ratio1.671.492.145
Pretty Stable
Price Cash Flow Ratio5.15.274.6222
Slightly volatile
Enterprise Value Multiple2.242.253.9348
Slightly volatile
Debt Ratio0.05640.05940.1661
Slightly volatile
Cash Flow To Debt Ratio3.172.611.2662
Slightly volatile
Price Sales Ratio0.70.860.6673
Slightly volatile
Return On Assets0.06640.130.0887
Slightly volatile
Asset Turnover0.780.830.7082
Pretty Stable
Net Profit Margin0.0960.180.1281
Pretty Stable
Gross Profit Margin0.430.530.5487
Very volatile
Price Fair Value0.860.850.7952
Pretty Stable
Return On Equity0.10.180.1459
Very volatile

Dr Reddys Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap196.7 B187.3 B114 B
Slightly volatile
Enterprise Value208.9 B199 B149 B
Slightly volatile

RDY Fundamental Market Drivers

Forward Price Earnings16.3399
Cash And Short Term Investments81.5 B

RDY Upcoming Events

31st of January 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
8th of May 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of March 2023
Last Financial Announcement
View

About Dr Reddys Financial Statements

Dr Reddys investors use historical fundamental indicators, such as Dr Reddys' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Dr Reddys. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue1.3 B1.2 B
Total Revenue321 B337.1 B
Cost Of Revenue132.9 B139.5 B
Sales General And Administrative To Revenue 0.17  0.15 
Research And Ddevelopement To Revenue 0.07  0.07 
Capex To Revenue 0.09  0.07 
Revenue Per Share1.5 K1.6 K
Ebit Per Revenue 0.22  0.11 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for RDY Stock Analysis

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.